Core Insights - Stanley Druckenmiller has a remarkable investing history, achieving an average annual return of 30% over three decades without any money-losing years [1] - Despite retiring from Duquesne Capital Management, he continues to manage investments through the Duquesne Family Office and has made notable moves recently [2] Company Actions - Druckenmiller sold all shares of Nvidia and Palantir, two leading AI companies, which have seen stock gains of 1,400% and 2,300% respectively over the past three years [3] - He expressed regret over selling Nvidia, referring to it as "a wonderful company," but cited increased valuation as a reason for the sale [5] - The exit from Palantir may also be attributed to its high valuation, trading at over 125 times forward earnings estimates during the sale period [6] Recent Investments - Druckenmiller has recently invested in Eli Lilly, a leader in the weight loss drug market, purchasing 62,190 shares in the fourth quarter of last year and increasing his holdings to 100,675 shares [8] - Additionally, he opened a position in Viking Therapeutics, acquiring 549,295 shares in the second quarter of this year [8]

Core Insights - Viking Therapeutics, Inc. (NASDAQ: VKTX) has experienced a significant drop of 50% in its stock price despite strong clinical advancements in obesity and NASH, attributed to broader market concerns [1] Group 1 - The article discusses the recent performance of VKTX, highlighting the disconnect between its clinical progress and stock performance [1] - The author emphasizes the potential of VKTX in the biotech sector, particularly in developing breakthrough therapies [1] - The article mentions the author's long position in VKTX and other pharmaceutical companies, indicating a personal investment interest [2] Group 2 - The author has a background in healthcare investment and focuses on innovative companies with potential acquisition catalysts [1] - The article is part of a subscription marketplace service called Compounding Healthcare, which offers various investment resources [1]